Insilico exploration of the potential inhibitory activity of DrugBank compounds against CDK7 kinase using structure-based virtual screening, molecular docking, and dynamics simulation approach
Authors:
- Afzal HussainAHAfzal Hussain
- Ashfaq HussainAHAshfaq Hussain
- Nazmiara SabnamNSNazmiara Sabnam
- Chandan Kumar VermaCVChandan Kumar Verma
- Namita ShrivastavaNSNamita Shrivastava
Open Access
- 1 February 2023
- journal article
- research article
- Published by Scientific Scholar in Arabian Journal of Chemistry
- Vol. 16 (2)
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Super-Enhancer-Driven Transcriptional Dependencies in CancerTrends in Cancer, 2017
- Investigating Protein–Peptide Interactions Using the Schrödinger Computational Suite2017
- Transcriptional Addiction in CancerCell, 2017
- Expression of CDK7, Cyclin H, and MAT1 Is Elevated in Breast Cancer and Is Prognostic in Estrogen Receptor–Positive Breast CancerClinical Cancer Research, 2016
- Computer Aided Drug Design: Success and LimitationsCurrent Pharmaceutical Design, 2016
- Identification of novel inhibitors against Cyclin Dependent Kinase 9/Cyclin T1 complex as: Anti cancer agentSaudi Journal of Biological Sciences, 2015
- GROMACS: High performance molecular simulations through multi-level parallelism from laptops to supercomputersSoftwareX, 2015
- The Crystal Structure of Human CDK7 and Its Protein Recognition PropertiesStructure, 2004
- Cdk7 is essential for mitosis and for in vivo Cdk-activating kinase activityGenes & Development, 1998
- Principles of CDK regulationNature, 1995